Intriguingly, the mean relative tumor volume significantly decreased from 4 in IgG to 1.8 with combo treatment of CXCL16 NAb and anti-PD-1 antibody compared with anti-PD-1 alone (Fig. 4k and Supplementary Fig. 4g). The gene discussed is CXCL16; the disease is neoplasm.